An open-label study in healthy participants to evaluate AZD0780 as an object or precipitant of CYP3A4-mediated drug-drug interactions

Trial Identifier:	D7960C00011
Sponsor:	AstraZeneca
Start Date:	September 2024
Primary Completion Date:	February 2025
Study Completion Date:	February 2025
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.